CymaBay Therapeutics Inc. (CBAY) Gained 11.4% or 1.16 To Price $11.34 On Friday


CymaBay Therapeutics Inc. (CBAY) gained 11.4% or 1.16 to $11.34. It is around 1.16 million shares traded, which is 181.34% compare to the average total volume 641603. The market cap of CBAY is $674.04 million. The year to date change is 34.64%. The 52 week price range is from $6.31 to $15.59. Price of CBAY have changed 4.20% during last week. It have changed 14.25% over last month, 14.00% over last 3 months, -14.95% over last 6 months and -32.04% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for CBAY is 8.79. It is -22.49% below current price. The 200-day Moving Averages for CBAY is 11.02. It is -2.82% below current price. The 52-week High is 15.59. It is 37.48% from the current price. The 52-week Low is 6.31. It is -44.36% from current price.

There are some statistics of CBAY. It is has market cap $674.04 million. The share outstanding is 59.44 million. The average volume is 641603. The percent of top 15 Institution holding is 122.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of CBAY is -42.48%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of CBAY is -37.88%.


Tags:

Share this post